We promote and protect the health and safety of Idahoans

Medical > Prescription Drugs > P&T Committee

Pharmacy and Therapeutics Committee

The Pharmacy & Therapeutics Committee is a select group of learned individuals committed to providing the right care at the right price.

To that end, the Committee meets four times per year to review clinical evidence. Drug utilization review and cost modeling analysis are done twice per year - at the committee meetings in February and August.

The Committee makes recommendations to the Department of Health and Welfare regarding which drugs they found to be the most efficacious and whether or not to prior authorize any of the agents.

Please click here for the Preferred Agent by Drug Class List.

2009 Meeting Dates

2009

January 16

February 20

July 17

August 21

P&T Drug Review Schedule for 2009

P & T Meeting

Date

New Reviews

Re-Reviews

January 16, 2009**

· Cough and Cold Products

· Endothelin Receptor Antagonists

·   Hypoglycemics, TZD

·   Hypoglycemics, Meglitinides

·   Angiotensin Modulators

·   Angiotensin Modulators/CCB Combo Drugs

·   Calcium Channel Blockers

·   Beta Blockers

·   Lipotropics, Statins

·   Lipotropics, Other

·   BPH Agents

·   Bladder Relaxant Preparations

·   Phosphate Binders

·   Erythropoesis Stimulating Proteins

·   Anticoagulants, Injectible

·   Proton Pump Inhibitors

February 20, 2009*

· H Pylori Agents

· GI Antibiotics

· Anticonvulsants (epilepsy)

· Antiepileptic Drugs for Nonepilepsy Conditions

· Analgesics, Narcotics Long-Acting

· Analgesics, Narcotics, Short-Acting

· Antimigraine Agents, Triptans

· Multiple Sclerosis Agents

· Skeletal Muscle Relaxants

· Ulcerative Colitis Agents

· Growth Hormone

· Newer Insomnia Drugs

·   Antihistamines, Minimally Sedating

·   Hepatitis C Agents

·   Impetigo Agents, Topical

·   Otic Fluoroquinolones

July 17, 2009***

· Quick Relief Medications for Asthma

· Controller Medications for Asthma (Leukotriene Modifiers, Inhaled Glucocorticoids, Beta Agonist Brochodilators)

· Bronchodilators, Anticholinergic

· Ophthalmics for Allergic Conjunctivitis

· Intranasal Rhinitis Agents

· Cephalosporins & Related Antibiotics

· Fluoroquinolones, Oral

· Macrolides/Ketolides

· Toopical Calcineurin Inhibiotrs (Atopic Derm)

· Antivirals, Oral

· Antivirals, Topical

· Ophthalmics, Fluoroquinolones

· Antifungals, Oral

· Antifungals, Topical

· Vaginal Antibiotics

· Antiparasitics, Topical

· Hepatitis B Agents

August 21, 2009***

· Hypoglycemics, Insulins and Related Agents

· Newer Drugs for Treatment of Diabetes

· Newer Antiemetics

· Pancreatic Enzymes

· Androgenic Agents

· Alzheimer's Drugs

· Platelet Aggregation Inhibitors

· Targeted Immune Modulators (Cytokine/CAM Antagonists)

· Second Generation Antidepressants

· Stimulants & Related Agents

· Antiparkinson's Agents

· Analgesics/Anesthetics, Topical

· NSAIDS

· Bone Resorption Supression & Related Agents

· Ophthalmics, Glaucoma Agents

· Ophthalmics, NSAIDS

*The P&T Committee will review the financial information and make PDL recommendations for these classes during Closed Executive Session at the conclusion of this meeting.

** The P&T Committee will review the financial information and make PDL recommendations for these classes during Closed Executive Session at the conclusion of the February 20, 2009 P&T Committee meeting.

***Financial information will be reviewed and PDL recommendations made by the Idaho Department of Health and Welfare at the conclusion of the August 21, 2009 meeting.

Black = OHSU based Review
Green = Provider Synergies based Review